Literature DB >> 28063630

Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes.

Yirong Wang1, Ruhong Cheng1, Zhiyong Lu1, Yifeng Guo1, Ming Yan1, Jianying Liang1, Peichen Huang1, Ming Li2, Zhirong Yao3.   

Abstract

BACKGROUND: IL36RN mutation has been identified as one pathogenesis of generalized pustular psoriasis, but the existence of GPP patients without mutation makes this controversial.
OBJECTIVE: Our study aimed at assessing the differences in clinical profiles of children with GPP, with and without IL36RN mutation.
METHODS: An ambispective case series study involved review of the records of 66 childhood patients with pediatric-onset GPP and without previous psoriasis vulgaris.
RESULTS: c.115+6T>C was the most common mutation in this Chinese population with GPP alone. The age at onset was nearly halved in the homozygotes/compound heterozygotes than in IL36RN-negative patients. Besides a more severe inflammatory progression, three minor signs could prioritize patients with GPP for IL36RN screening (confluent lakes of pus (P=0.002), perianal erosion (P=0.014), and flexural erosion (P=0.007)). More patients with the pathogenic mutation converted to ACH than those without mutation (χ2=4.773, P=0.029). Children with GPP with or without IL36RN mutation responded well to oral low-dose acitretin, but IL36RN-positive cases suffered a much higher half-year recurrence rate after withdrawl of acitretin treatment(χ2=10.370, P=0.001).
CONCLUSIONS: Specific clinical features can remind dermatologists of the necessity of sequencing diagnosis. The mild pustular phenotype of those without mutation may imply the possible role of the epigenetic changes of IL36RN, or other IL36-blockers in the pathogenesis. Pediatric patients with GPP alone, both with and without IL36RN mutation responded well to low-dose acitretin. Copyright Â
© 2016 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acitretin; Children; Generalized pustular psoriasis; IL36RN gene mutation

Mesh:

Substances:

Year:  2016        PMID: 28063630     DOI: 10.1016/j.jdermsci.2016.11.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  4 in total

1.  A mysterious abdominal pain during active psoriasis.

Authors:  Valentina Della Valle; Marco Maggioni; Carlo Carrera; Angelo Cattaneo; Angelo Valerio Marzano; Giovanni Damiani
Journal:  Intern Emerg Med       Date:  2017-10-30       Impact factor: 3.397

2.  Abdominal giant epidermoid cyst with squamous epithelial heterogeneous proliferation carcinoma in part of the cyst wall: a case report.

Authors:  Tao Hu; Dong Wang; Yuan Tian; Xinyv Yuan; Yong Li
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

Review 3.  The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications.

Authors:  Rohan Singh; Sindhuja Koppu; Patrick O Perche; Steven R Feldman
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

4.  Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Zhi-Jie Liu; Yu-Tong Tian; Bo-Yi Shi; Yin Zhou; Xue-Song Jia
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.